![]() |
![]() |
|
![]() |
OFT Study Into UK Medicines Distribution
LegalDay - News and Links for UK Law
Medicines Distribution - Medicine Suppliers - Prescription Drugs - NHS - Pfizer - Unichem
|
LegalDay
Home
Cases
CurrentIssues
LegalPractice
Jobs
News
SiteMap
|
|
Click
Here for the Latest Legal News
04 April 2007
Office of Fair Trading OFT Study Into UK Medicines Distribution
OFT launches market study into UK medicines distribution The OFT has today launched a market study into the distribution of medicines in the UK. This decision follows recent and proposed distribution changes by leading UK medicine suppliers. Until recently all medicines were distributed through a number of competing wholesalers but in March 2007 Pfizer Limited began selling prescription drugs solely through one wholesaler, Unichem. Other suppliers are also considering introducing significant changes to their own distribution arrangements. The study will consider the likely impact of such changes on competition, the NHS and patients and will report back by the end of the year. Download a short document outlining why UK medicines distribution meets the prioritisation criteria for launching a study, and the focus and timescales of the study from the OFT website - http://www.oft.gov.uk. The decision to undertake a market study reflects the importance of ensuring that the distribution of medicines involving pharmacists, hospitals and dispensing doctors, is timely, efficiently delivered and cost effective for patients. The NHS spends more than £10 billion per year on the purchase of prescription medicines. UK pharmacies currently provide more than 800 million prescriptions per year. At the end of the market study, the OFT will have a better understanding of the impact of the changes that are taking place and whether further action is required. Ann Pope, OFT Director in Markets and Projects, said: NOTES 2. Healthcare is an OFT priority sector. The efficient distribution of medicines is necessary to their timely and cost effective provision. In February the OFT also recommended that the Pharmaceutical Price Regulation Scheme (PPRS) should be reformed, to deliver better value for money from NHS drug spend and to focus business investment on drugs that have the greatest benefits for patients. 3. The gathering of information in market studies is undertaken by the OFT under section 5 of the Enterprise Act 2002. Possible outcomes of a market study include: giving the market a clean bill of health; publishing information to help consumers; encouraging firms to take voluntary action; encouraging a consumer code of practice; making recommendations to the Government or sector regulators; investigation and enforcement action against companies suspected of breaching consumer or competition law; a market investigation reference to the Competition Commission. PUBLIC enquiries: 0845 7224499
|
|
Legalday Related Pages Competition Law LinksMedical Law Pharmaceuticals Contact
Fleetbank House More Commentaries From
OFT Raids Companies Suspected of Marine Hose Cartel Author/Firm Profile |
Legalday Home
Recently On LegalDay
Browse Archives By Date
Disclaimer
© Day x Day Media Ltd 2006 - All worldwide rights strictly reserved